The Food and Drugs Authority (FDA), in collaboration with medicine regulatory agencies and non-governmental organizations, has initiated a medicine safety monitoring campaign titled “#MedSafetyWeek.”
Spanning from the sixth to the 12th of November 2023, the campaign is expected to intensify awareness surrounding the reporting of medicine side effects, focusing on the theme “Who can report.”
According to a statement released to the Ghana News Agency, the campaign underscores the role played by patients, caregivers, doctors, nurses, and pharmacists in reporting side effects, thereby contributing significantly to overall medicine safety.
The FDA emphasized the importance of gathering information on known side effects while remaining vigilant about identifying new ones.
The collected data according to the Authority will enable the FDA to identify potential risks associated with medicines, facilitating timely regulatory interventions to enhance overall medicine safety.
They encouraged the public to utilize reporting forms available in healthcare facilities, designated patient safety centers, or the user-friendly Med Safety App, available for free on the App Store or Google Play Store.
They further urged individuals to report to any FDA regional office for thorough assessment, ensuring the right steps are taken to protect public health and safety.